BSE filing, NSE: DECCANCE. Summary written from the filing by ALFA Finder's alert engine.
Deccan Cements Ltd: key numbers
- Share price
- ₹473.50
- Market cap
- ₹663.3 Cr
- Revenue (annual)
- ₹635.6 Cr
- Net profit (annual)
- ₹28.58 Cr
- P/E (TTM)
- 113.6×Sector 31.7×
- Promoter holding
- 56.25%+0.00% QoQ
- FII holding
- 14.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Deccan Cements Ltd
All →Deccan Cements Annual General Meeting
Deccan Cements Limited held its 46th Annual General Meeting on 29th September 2026. The meeting transacted ordinary and special business, including financial statement adoption and dividend approval.
Deccan Cements Annual General Meeting
Deccan Cements Limited scheduled its 46th Annual General Meeting for September 29, 2026, and submitted the accompanying 46th Annual Report for the financial year 2025-26.
Deccan Cements Credit Rating
Deccan Cements clarified that Infomerics Valuation and Rating Limited conducted a rating review for a previously withdrawn Rs. 50 Crore NCD proposal, despite the company's request.
Deccan Cements Other Announcement
Deccan Cements filed its Monitoring Agency report for the quarter ended June 30, 2026, confirming the full utilization of Rs. 102.99 Crore raised via CCDs.
- Value
- ₹103.0 Cr
Deccan Cements Credit Rating
Deccan Cements received a credit rating update from CARE Ratings, with long-term bank facilities downgraded to CARE BBB/Stable and short-term ratings reaffirmed at CARE A3+.
Deccan Cements Dividend
Deccan Cements fixed September 22, 2026, as the record date for its previously recommended final dividend of Re. 0.50 per equity share for FY 2025-26.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.